NR5A2 and cancer: We further explored whether key canonical target genes of FXR (i.e., SHP, NR5A2/LRH-1, FGF19, PLTP, SDC-1)27 are associated with resistance to ferroptosis inducers by using the Cancer Therapeutics Response Portal (CTRP)28.